All In Biotech

Drug Trial Radar · NCT01449162

Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids

A Prospective, Multicenter, Randomised, Double-blind, Placebo-controlled, 2-parallel Groups, Phase 3 Study to Compare the Efficacy and the Safety of Masitinib at 6 mg/kg/Day Versus Placebo in the Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids

Last checked: Nov 19, 2026Latest source record: Feb 10, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 420 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

420

Actual

Start

Jan 2011

Primary completion

Nov 2019

Study completion Nov 2019

Sponsor

Lead sponsor
AB ScienceIndustry
Sponsor type
Industry
First posted
Oct 10, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study objective is to compare the efficacy and the safety of masitinib at 6 mg/kg/day versus placebo in the treatment of patients with Severe Persistent Asthma treated with oral corticosteroids.

Conditions

  • Asthma

Interventions

  • MasitinibDrug

    6 mg/kg/day

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Severe asthma exacerbation rateTime frame: Duration of patient treatment exposure, assessed until withdrawal from study, study completion date, or for a maximum of 60 months

Locations

8 sites in 6 countries. Site status is shown where the registry gives one.

  • Dr. Georgi Stranski University Hospital

    Pleven, Bulgaria

  • Hospital Polyclinic Melnik

    Mělník, Czechia

  • Hospital La Cavale Blanche

    Brest, France

  • l'Hopital Albert Calmette

    Lille, France

  • l'Hopital de la Croix Rousse

    Lyon, France

  • University of Debrecen Medical and Health Science Center

    Debrecen, Hungary

  • King George Hospital

    Hyderabad, India

  • Hospital Universitario Doctor Peset

    Valencia, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.